» Articles » PMID: 22016483

Emphysema Scores Predict Death from COPD and Lung Cancer

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2011 Oct 22
PMID 22016483
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Our objective was to assess the usefulness of emphysema scores in predicting death from COPD and lung cancer.

Methods: Emphysema was assessed with low-dose CT scans performed on 9,047 men and women for whom age and smoking history were documented. Each scan was scored according to the presence of emphysema as follows: none, mild, moderate, or marked. Follow-up time was calculated from time of CT scan to time of death or December 31, 2007, whichever came first. Cox regression analysis was used to calculate the hazard ratio (HR) of emphysema as a predictor of death.

Results: Median age was 65 years, 4,433 (49%) were men, and 4,133 (46%) were currently smoking or had quit within 5 years. Emphysema was identified in 2,637 (29%) and was a significant predictor of death from COPD (HR, 9.3; 95% CI, 4.3-20.2; P < .0001) and from lung cancer (HR, 1.7; 95% CI, 1.1-2.5; P = .013), even when adjusted for age and smoking history.

Conclusions: Visual assessment of emphysema on CT scan is a significant predictor of death from COPD and lung cancer.

Citing Articles

Diagnosis and management of comorbid disease in COPD.

Cronin E, Cushen B Breathe (Sheff). 2025; 21(1):240099.

PMID: 40007528 PMC: 11851148. DOI: 10.1183/20734735.0099-2024.


The causal and mediation effect of chronic obstructive pulmonary disease on lung cancer subtypes: a two-sample mendelian randomization study.

Zhang X, Zhang J, Wang Z Cancer Causes Control. 2024; 36(1):13-19.

PMID: 39276304 DOI: 10.1007/s10552-024-01916-x.


The association of chest computed tomography-defined visual emphysema and prognosis in patients with nonsmall cell lung cancer.

Zhang Y, Yi J, Sun D, Su Y, Zuo Y, Zhu M ERJ Open Res. 2023; 9(6).

PMID: 38020560 PMC: 10658642. DOI: 10.1183/23120541.00195-2023.


ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.

ODowd E, Tietzova I, Bartlett E, Devaraj A, Biederer J, Brambilla M Eur J Cardiothorac Surg. 2023; 64(4).

PMID: 37804174 PMC: 10876118. DOI: 10.1093/ejcts/ezad302.


Nomogram combining clinical and radiological characteristics for predicting the malignant probability of solitary pulmonary nodules measuring ≤ 2 cm.

Xue M, Li R, Wang K, Liu W, Liu J, Li Z Front Oncol. 2023; 13:1196778.

PMID: 37795448 PMC: 10545867. DOI: 10.3389/fonc.2023.1196778.


References
1.
Bang K, Gergen P, Kramer R, Cohen B . The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest. 1993; 103(2):536-40. DOI: 10.1378/chest.103.2.536. View

2.
Ueda K, Jinbo M, Li T, Yagi T, Suga K, Hamano K . Computed tomography-diagnosed emphysema, not airway obstruction, is associated with the prognostic outcome of early-stage lung cancer. Clin Cancer Res. 2006; 12(22):6730-6. DOI: 10.1158/1078-0432.CCR-06-1196. View

3.
Li Y, Swensen S, Gunbey Karabekmez L, Marks R, Stoddard S, Jiang R . Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment. Cancer Prev Res (Phila). 2010; 4(1):43-50. PMC: 3018159. DOI: 10.1158/1940-6207.CAPR-10-0151. View

4.
Anthonisen N, Skeans M, Wise R, Manfreda J, Kanner R, Connett J . The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005; 142(4):233-9. DOI: 10.7326/0003-4819-142-4-200502150-00005. View

5.
Hansell A, Walk J, Soriano J . What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J. 2003; 22(5):809-14. DOI: 10.1183/09031936.03.00031403. View